Q3 2020 ADMA Biologics Inc Earnings Call Transcript
Good afternoon and welcome to the ADMA Biologics Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020. (Operator Instructions) Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately 2 hours following the end of the call.
At this time, I would like to introduce Skyler Bloom, Director, Investor Relations and Corporate Strategy at ADMA Biologics. Please go ahead.
Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics financial results for the third quarter of 2020. I'm joined today by Adam Grossman, President and Chief Executive Officer; and Brian Lenz, Executive Vice President and Chief Financial Officer. Today's call, Adam will provide some introductory comments and provide a corporate update, and then Brian will provide an overview of the company's third quarter and 9 months ended September 30, 2020, financial results. Adam will then
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |